<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37294299</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2050-084X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2023</Year><Month>Jun</Month><Day>09</Day></PubDate></JournalIssue><Title>eLife</Title><ISOAbbreviation>Elife</ISOAbbreviation></Journal><ArticleTitle>Changes in transmission of Enterovirus D68 (EV-D68) in England inferred from seroprevalence data.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e76609</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7554/eLife.76609</ELocationID><Abstract><AbstractText>The factors leading to the global emergence of Enterovirus D68 (EV-D68) in 2014 as a cause of acute flaccid myelitis (AFM) in children are unknown. To investigate potential changes in virus transmissibility or population susceptibility, we measured the seroprevalence of EV-D68-specific neutralising antibodies in serum samples collected in England in 2006, 2011, and 2017. Using catalytic mathematical models, we estimate an approximately 50% increase in the annual probability of infection over the 10-year study period, coinciding with the emergence of clade B around 2009. Despite such increase in transmission, seroprevalence data suggest that the virus was already widely circulating before the AFM outbreaks and the increase of infections by age cannot explain the observed number of AFM cases. Therefore, the acquisition of or an increase in neuropathogenicity would be additionally required to explain the emergence of outbreaks of AFM. Our results provide evidence that changes in enterovirus phenotypes cause major changes in disease epidemiology.</AbstractText><CopyrightInformation>© 2023, Pons-Salort et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pons-Salort</LastName><ForeName>Margarita</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5597-9285</Identifier><AffiliationInfo><Affiliation>MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamau</LastName><ForeName>Everlyn</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pebody</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Immunization Department, Public Health England, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harvala</LastName><ForeName>Heli</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Infection and Immunity, University College of London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simmonds</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grassly</LastName><ForeName>Nicholas C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>216427/Z/19/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>ISSF204826/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Elife</MedlineTA><NlmUniqueID>101579614</NlmUniqueID><ISSNLinking>2050-084X</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000629404">acute flaccid myelitis</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>doi: 10.1101/2021.11.08.21265913</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009468" MajorTopicYN="Y">Neuromuscular Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus D68</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">global health</Keyword><Keyword MajorTopicYN="N">mathematical model</Keyword><Keyword MajorTopicYN="N">seroepidemiology</Keyword><Keyword MajorTopicYN="N">viruses</Keyword></KeywordList><CoiStatement>MP, BL, EK, RP, HH, PS, NG No competing interests declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>13</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>10</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37294299</ArticleId><ArticleId IdType="pmc">PMC10259368</ArticleId><ArticleId IdType="doi">10.7554/eLife.76609</ArticleId><ArticleId IdType="pii">76609</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ayscue P, Van Haren K, Sheriff H, Waubant E, Waldron P, Yagi S, Yen C, Clayton A, Padilla T, Pan C, Reichel J, Harriman K, Watt J, Sejvar J, Nix WA, Feikin D, Glaser C, Centers for Disease Control and Prevention (CDC) Acute flaccid paralysis with anterior myelitis - California, June 2012-June 2014. MMWR. Morbidity and Mortality Weekly Report. 2014;63:903–906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4584614</ArticleId><ArticleId IdType="pubmed">25299608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bal A, Sabatier M, Wirth T, Coste-Burel M, Lazrek M, Stefic K, Brengel-Pesce K, Morfin F, Lina B, Schuffenecker I, Josset L. Emergence of enterovirus D68 clade D1, France, August to November 2018. Euro Surveillance. 2019;24:1800699. doi: 10.2807/1560-7917.ES.2019.24.3.1800699.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2019.24.3.1800699</ArticleId><ArticleId IdType="pmc">PMC6344839</ArticleId><ArticleId IdType="pubmed">30670143</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L, Wang Y, Yao X, Mao Q, Xu M, Liang Z. Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Review of Anti-Infective Therapy. 2015;13:1061–1071. doi: 10.1586/14787210.2015.1058156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2015.1058156</ArticleId><ArticleId IdType="pubmed">26112307</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DM, Hixon AM, Oldfield LM, Zhang Y, Novotny M, Wang W, Das SR, Shabman RS, Tyler KL, Scheuermann RH. Contemporary circulating enterovirus D68 strains have acquired the capacity for viral entry and replication in human neuronal cells. MBio. 2018;9:e01954-18. doi: 10.1128/mBio.01954-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01954-18</ArticleId><ArticleId IdType="pmc">PMC6191546</ArticleId><ArticleId IdType="pubmed">30327438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bubba L, Broberg EK, Jasir A, Simmonds P, Harvala H, Enterovirus study collaborators Circulation of non-polio enteroviruses in 24 EU and EEA countries between 2015 and 2017: a retrospective surveillance study. The Lancet. Infectious Diseases. 2020;20:350–361. doi: 10.1016/S1473-3099(19)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30566-3</ArticleId><ArticleId IdType="pubmed">31870905</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  Case Definitions for AFM. 2021.  [June 4, 2021]. https://www.cdc.gov/acute-flaccid-myelitis/hcp/case-definitions.html</Citation></Reference><Reference><Citation>Chong PF, Kira R, Mori H, Okumura A, Torisu H, Yasumoto S, Shimizu H, Fujimoto T, Hanaoka N, Kusunoki S, Takahashi T, Oishi K, Tanaka-Taya K, Acute Flaccid Myelitis Collaborative Study Investigators Clinical features of acute flaccid myelitis temporally associated with an enterovirus D68 outbreak: results of a nationwide survey of acute flaccid paralysis in Japan, August-December 2015. Clinical Infectious Diseases. 2018;66:653–664. doi: 10.1093/cid/cix860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix860</ArticleId><ArticleId IdType="pmc">PMC5850449</ArticleId><ArticleId IdType="pubmed">29028962</ArticleId></ArticleIdList></Reference><Reference><Citation>Dighe A. The Transmission Dynamics of Middle East Respiratory Syndrome Coronavirus in Dromedary Camels: Implications for Vaccination. London: Imperial College London; 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.25560/101243</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyrdak R, Mastafa M, Hodcroft EB, Neher RA, Albert J. Intra- and interpatient evolution of enterovirus D68 analyzed by whole-genome deep sequencing. Virus Evolution. 2019;5:vez007. doi: 10.1093/ve/vez007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vez007</ArticleId><ArticleId IdType="pmc">PMC6482344</ArticleId><ArticleId IdType="pubmed">31037220</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, Sagulenko P, Bedford T, Neher RA. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018;34:4121–4123. doi: 10.1093/bioinformatics/bty407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty407</ArticleId><ArticleId IdType="pmc">PMC6247931</ArticleId><ArticleId IdType="pubmed">29790939</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison CJ, Weldon WC, Pahud BA, Jackson MA, Oberste MS, Selvarangan R. Neutralizing antibody against enterovirus D68 in children and adults before 2014 outbreak. Emerging Infectious Diseases. 2019;25:585–588. doi: 10.3201/eid2503.180960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2503.180960</ArticleId><ArticleId IdType="pmc">PMC6390745</ArticleId><ArticleId IdType="pubmed">30789123</ArticleId></ArticleIdList></Reference><Reference><Citation>Hens N, Aerts M, Faes C, Shkedy Z, Lejeune O, Van Damme P, Beutels P. Seventy-five years of estimating the force of infection from current status data. Epidemiology and Infection. 2010;138:802–812. doi: 10.1017/S0950268809990781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268809990781</ArticleId><ArticleId IdType="pubmed">19765352</ArticleId></ArticleIdList></Reference><Reference><Citation>Hens N, Shkedy Z, Aerts M, Faes C, Van Damme P, Beutels P. Modeling Infectious Disease Parameters Based on Serological and Social Contact Data: Springer-Verlag. New York: Springer; 2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4614-4072-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon AM, Frost J, Rudy MJ, Messacar K, Clarke P, Tyler KL. Understanding enterovirus D68-induced neurologic disease: A basic science review. Viruses. 2019;11:821. doi: 10.3390/v11090821.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11090821</ArticleId><ArticleId IdType="pmc">PMC6783995</ArticleId><ArticleId IdType="pubmed">31487952</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm-Hansen CC, Midgley SE, Fischer TK. Global emergence of enterovirus D68: a systematic review. The Lancet. Infectious Diseases. 2016;16:e64–e75. doi: 10.1016/S1473-3099(15)00543-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00543-5</ArticleId><ArticleId IdType="pubmed">26929196</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura T, Okamoto M, Nakakita S, Suzuki A, Saito M, Tamaki R, Lupisan S, Roy CN, Hiramatsu H, Sugawara K, Mizuta K, Matsuzaki Y, Suzuki Y, Oshitani H. Antigenic and receptor binding properties of enterovirus 68. Journal of Virology. 2014;88:2374–2384. doi: 10.1128/JVI.03070-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03070-13</ArticleId><ArticleId IdType="pmc">PMC3958110</ArticleId><ArticleId IdType="pubmed">24371050</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadambari S, Bukasa A, Okike IO, Pebody R, Brown D, Gallimore C, Xerry J, Sharland M, Ladhani SN. Enterovirus infections in England and Wales, 2000-2011: the impact of increased molecular diagnostics. Clinical Microbiology and Infection. 2014;20:1289–1296. doi: 10.1111/1469-0691.12753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-0691.12753</ArticleId><ArticleId IdType="pubmed">25039903</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamau E, Harvala H, Blomqvist S, Nguyen D, Horby P, Pebody R, Simmonds P. Increase in enterovirus D68 infections in young children, United Kingdom, 2006-2016. Emerging Infectious Diseases. 2019;25:1200–1203. doi: 10.3201/eid2506.181759.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2506.181759</ArticleId><ArticleId IdType="pmc">PMC6537723</ArticleId><ArticleId IdType="pubmed">30855226</ArticleId></ArticleIdList></Reference><Reference><Citation>Karelehto E, Koen G, Benschop K, van der Klis F, Pajkrt D, Wolthers K. Enterovirus D68 serosurvey: evidence for endemic circulation in the Netherlands, 2006 to 2016. Euro Surveillance. 2019;24:1800671. doi: 10.2807/1560-7917.ES.2019.24.35.1800671.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2019.24.35.1800671</ArticleId><ArticleId IdType="pmc">PMC6724466</ArticleId><ArticleId IdType="pubmed">31481149</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoester M, Helfferich J, Poelman R, Van Leer-Buter C, Brouwer OF, Niesters HGM, 2016 EV-D68 AFM Working Group Twenty-nine cases of enterovirus-D68-associated acute flaccid myelitis in Europe 2016: A case series and epidemiologic overview. The Pediatric Infectious Disease Journal. 2019;38:16–21. doi: 10.1097/INF.0000000000002188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002188</ArticleId><ArticleId IdType="pmc">PMC6296836</ArticleId><ArticleId IdType="pubmed">30234793</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay SL, Lee AD, Lopez AS, Nix WA, Dooling KL, Keaton AA, Spence-Davizon E, Herlihy R, Clark TA, Hopkins SE, Pastula DM, Sejvar J, Oberste MS, Pallansch MA, Patel M, Routh JA. Increase in acute flaccid myelitis - United States, 2018. MMWR. Morbidity and Mortality Weekly Report. 2018;67:1273–1275. doi: 10.15585/mmwr.mm6745e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6745e1</ArticleId><ArticleId IdType="pmc">PMC6290805</ArticleId><ArticleId IdType="pubmed">30439867</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Asturias EJ, Hixon AM, Van Leer-Buter C, Niesters HGM, Tyler KL, Abzug MJ, Dominguez SR. Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality. The Lancet Infectious Diseases. 2018;18:e239–e247. doi: 10.1016/S1473-3099(18)30094-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30094-X</ArticleId><ArticleId IdType="pmc">PMC6778404</ArticleId><ArticleId IdType="pubmed">29482893</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyers L, Dien Bard J, Galvin B, Nawrocki J, Niesters HGM, Stellrecht KA, St George K, Daly JA, Blaschke AJ, Robinson C, Wang H, Cook CV, Hassan F, Dominguez SR, Pretty K, Naccache S, Olin KE, Althouse BM, Jones JD, Ginocchio CC, Poritz MA, Leber A, Selvarangan R. Enterovirus D68 outbreak detection through a syndromic disease epidemiology network. Journal of Clinical Virology. 2020;124:104262. doi: 10.1016/j.jcv.2020.104262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104262</ArticleId><ArticleId IdType="pubmed">32007841</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley CM, Watson JT, Nix WA, Curns AT, Rogers SL, Brown BA, Conover C, Dominguez SR, Feikin DR, Gray S, Hassan F, Hoferka S, Jackson MA, Johnson D, Leshem E, Miller L, Nichols JB, Nyquist A-C, Obringer E, Patel A, Patel M, Rha B, Schneider E, Schuster JE, Selvarangan R, Seward JF, Turabelidze G, Oberste MS, Pallansch MA, Gerber SI, EV-D68 Working Group Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation. The Lancet. Respiratory Medicine. 2015;3:879–887. doi: 10.1016/S2213-2600(15)00335-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(15)00335-5</ArticleId><ArticleId IdType="pmc">PMC5693332</ArticleId><ArticleId IdType="pubmed">26482320</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Maher K, Schnurr D, Flemister MR, Lovchik JC, Peters H, Sessions W, Kirk C, Chatterjee N, Fuller S, Hanauer JM, Pallansch MA. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. The Journal of General Virology. 2004;85:2577–2584. doi: 10.1099/vir.0.79925-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.79925-0</ArticleId><ArticleId IdType="pubmed">15302951</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics  People, population and community. 2020.  [December 9, 2020]. https://www.ons.gov.uk/peoplepopulationandcommunity</Citation></Reference><Reference><Citation>Osborne K, Gay N, Hesketh L, Morgan-Capner P, Miller E. Ten years of serological surveillance in England and Wales: methods, results, implications and action. International Journal of Epidemiology. 2000;29:362–368. doi: 10.1093/ije/29.2.362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/29.2.362</ArticleId><ArticleId IdType="pubmed">10817137</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SW, Pons-Salort M, Messacar K, Cook C, Meyers L, Farrar J, Grenfell BT. Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis. Science Translational Medicine. 2021;13:584. doi: 10.1126/scitranslmed.abd2400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd2400</ArticleId><ArticleId IdType="pubmed">33692131</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M, Parker EPK, Grassly NC. The epidemiology of non-polio enteroviruses: recent advances and outstanding questions. Current Opinion in Infectious Diseases. 2015;28:479–487. doi: 10.1097/QCO.0000000000000187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000187</ArticleId><ArticleId IdType="pmc">PMC6624138</ArticleId><ArticleId IdType="pubmed">26203854</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M, Grassly NC. Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses. Science. 2018;361:800–803. doi: 10.1126/science.aat6777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat6777</ArticleId><ArticleId IdType="pmc">PMC6559928</ArticleId><ArticleId IdType="pubmed">30139872</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M. Analysis of enterovirus D68 (EV-D68) seroprevalence in England. swh:1:rev:0e91833969ab910f2939e3e73732cb5d80260b18Software Heritage. 2023 https://archive.softwareheritage.org/swh:1:dir:df7b31d14194e1d5bc5668482583809830bf9c22;origin=https://github.com/margapons/EV-D68_seroprevalence_England;visit=swh:1:snp:2745378c85c1e591996a7fbdf92648332a02abcd;anchor=swh:1:rev:0e91833969ab910f2939e3e73732cb5d80260b18</Citation></Reference><Reference><Citation>Public Health England  Risk assessment of enterovirus D-68 (EV-D68) 2018.  [November 16, 2021]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/750364/EVD68_RA_Oct_2018_final_19.10.pdf</Citation></Reference><Reference><Citation>Public Health England  Enterovirus: summary of strain characterisation. 2023.  [November 16, 2021]. https://www.gov.uk/government/publications/enterovirus-strain-characterisation/enterovirus-summary-of-strain-characterisation</Citation></Reference><Reference><Citation>Rosenfeld AB, Warren AL, Racaniello VR. Neurotropism of enterovirus D68 isolates is independent of sialic acid and is not a recently acquired phenotype. MBio. 2019;10:e02370-19. doi: 10.1128/mBio.02370-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02370-19</ArticleId><ArticleId IdType="pmc">PMC6805996</ArticleId><ArticleId IdType="pubmed">31641090</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar JJ, Lopez AS, Cortese MM, Leshem E, Pastula DM, Miller L, Glaser C, Kambhampati A, Shioda K, Aliabadi N, Fischer M, Gregoricus N, Lanciotti R, Nix WA, Sakthivel SK, Schmid DS, Seward JF, Tong S, Oberste MS, Pallansch M, Feikin D. Acute flaccid myelitis in the United States, August-December 2014: results of nationwide surveillance. Clinical Infectious Diseases. 2016;63:737–745. doi: 10.1093/cid/ciw372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw372</ArticleId><ArticleId IdType="pmc">PMC5709818</ArticleId><ArticleId IdType="pubmed">27318332</ArticleId></ArticleIdList></Reference><Reference><Citation>Stan Development Team  Rstan: the R interface to Stan. R Package. 2020 https://cran.r-project.org/web/packages/rstan/vignettes/rstan.html</Citation></Reference><Reference><Citation>Sun SY, Gao F, Hu YL, Bian LL, Mao QY, Wu X, Li JX, Zhu FC, Wang JW, Liang ZL. Seroepidemiology of enterovirus D68 infection in infants and children in Jiangsu, China. The Journal of Infection. 2018a;76:563–569. doi: 10.1016/j.jinf.2018.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2018.02.003</ArticleId><ArticleId IdType="pubmed">29428227</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Gao F, Hu Y, Bian L, Wu X, Su Y, Du R, Fu Y, Zhu F, Mao Q, Liang Z. A cross-sectional seroepidemiology study of EV-D68 in China. Emerging Microbes &amp; Infections. 2018b;7:99. doi: 10.1038/s41426-018-0103-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-018-0103-4</ArticleId><ArticleId IdType="pmc">PMC5988671</ArticleId><ArticleId IdType="pubmed">29872035</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan LK, Low SL, Sun H, Shi Y, Liu L, Lam S, Tan HH, Ang LW, Wong WY, Chua R, Teo D, Ng LC, Cook AR. Force of infection and true infection rate of dengue in Singapore implications for dengue control and management. American Journal of Epidemiology. 2019;188:1529–1538. doi: 10.1093/aje/kwz110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwz110</ArticleId><ArticleId IdType="pmc">PMC6670050</ArticleId><ArticleId IdType="pubmed">31062837</ArticleId></ArticleIdList></Reference><Reference><Citation>The United Kingdom Acute Flaccid Paralysis (AFP) Task Force An increase in reports of acute flaccid paralysis (AFP) in the United Kingdom, 1 January 2018–21 January 2019: early findings. Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 2019;24:1900093. doi: 10.2807/1560-7917.ES.2019.24.6.1900093.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2019.24.6.1900093</ArticleId><ArticleId IdType="pmc">PMC6373064</ArticleId><ArticleId IdType="pubmed">30755296</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokarz R, Firth C, Madhi SA, Howie SRC, Wu W, Sall AA, Haq S, Briese T, Lipkin WI. Worldwide emergence of multiple clades of enterovirus 68. Journal of General Virology. 2012;93:1952–1958. doi: 10.1099/vir.0.043935-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.043935-0</ArticleId><ArticleId IdType="pmc">PMC3542132</ArticleId><ArticleId IdType="pubmed">22694903</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehtari A, Gelman A, Gabry J. Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC. Statistics and Computing. 2017;27:1413–1432. doi: 10.1007/s11222-016-9696-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11222-016-9696-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehtari A, Gabry J, Magnusson M, Yao Y, Bürkner P, Paananen T. Loo: efficient leave-one-out cross-validation and WAIC for Bayesian models. 2.5.1 ed2022R Package. 2023 https://cran.r-project.org/web/packages/loo/loo.pdf</Citation></Reference><Reference><Citation>Vogt MR, Crowe JE. Current understanding of humoral immunity to enterovirus D68. Journal of the Pediatric Infectious Diseases Society. 2018;7:S49–S53. doi: 10.1093/jpids/piy124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piy124</ArticleId><ArticleId IdType="pubmed">30590621</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams CJ, Thomas RH, Pickersgill TP, Lyons M, Lowe G, Stiff RE, Moore C, Jones R, Howe R, Brunt H, Ashman A, Mason BW. Cluster of atypical adult Guillain-Barre syndrome temporally associated with neurological illness due to EV-D68 in children. Euro Surveillance. 2016;21 doi: 10.2807/1560-7917.ES.2016.21.4.30119.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.4.30119</ArticleId><ArticleId IdType="pubmed">26848143</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, Li L, Ren L, Guo L, Xie Z, Liu C, Li T, Luo M, Paranhos-Baccalà G, Xu W, Wang J. Seroepidemiology of enterovirus D68 infection in China. Emerging Microbes &amp; Infections. 2017;6:e32. doi: 10.1038/emi.2017.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2017.14</ArticleId><ArticleId IdType="pmc">PMC5520479</ArticleId><ArticleId IdType="pubmed">28487560</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>